DOT Drug Testing Rule – What it Means
On November 13, 2017 a new DOT drug testing rule was published. The rule added “four semi-synthetic opioids (i.e., hydrocodone, oxycodone, hydromorphone, oxymorphone)” to the drug testing panel. The DOT drug testing rule added “methylenedioxyamphetamine (MDA) as an initial test analyte and removed the testing for methylenedioxyethylamphetaime (MDEA).” How Does the New DOT Drug Testing […]